- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01401634
Oral Hydration for Mild to Moderate Hyperglycemia in the Emergency Department
July 22, 2011 updated by: University of Southern California
Diabetes and high blood sugar are extremely common among patients presenting to US Emergency Departments.
Intravenous fluids with or without insulin are often used to treat these patients.
However, simple, low-cost interventions, such oral hydration have not been studied in this context.
Oral rehydration may be better than no therapy at all, which is often what these patients receive in the first few hours when presenting to busy, overcrowded Emergency Department (ED) with long wait times, or in resource-poor environments such as developing countries.
The investigators propose a study to see if oral hydration for adult patients presenting to the ED with high blood sugar i.e. finger-stick (FS) values between 250 and 500 mg/dL can help lower blood sugar at the same rate as intravenous fluids.
Half the patients will be given intravenous fluids per our department protocol, while the other half of the patients will be given 2 liters of water to drink over a 1-hour period.
Both groups will have their blood sugar measured every 30 mins for 2 hours.
The investigators will analyze the data to determine if there is a statistically significant difference in blood sugar between the two groups within 2 hours.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90033
- University of Southern California
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any patient, above the age of 18 years old, presenting to Emergency Department triage with a fingerstick glucose between 250 and 500 mg/dL
Exclusion Criteria:
- Patients with evidence of DKA (hyperglycemia with ketonuria and abnormal pH or bicarbonate on venous blood gas), HHS, or other critical illnesses requiring immediate medical attention (as determined by ED triage nurses),
- end-stage renal disease requiring dialysis through an arterio-venous shunt or fistula,
- abnormal mental status (GCS < 15),
- unstable vital signs including pulse > 100, SBP < 100, respiratory rate>20, (or any combination of vital signs not meeting these cutoffs but deemed worrisome by the triage nurse) or unable to tolerate oral intake/actively vomiting.
- Patients who receive IV fluids prior to or during the study period.
- Patients unable to communicate in English or Spanish.
- Jail patients will also be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intravenous Fluids
Intravenous fluids for patients with hyperglycemia is part of the standard protocol in our department
|
2 Liters Intravenous normal saline
|
Experimental: Oral Fluids
|
2 Liters of water given orally
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Blood Sugar
Time Frame: 2 hours
|
Patients will have their blood sugar checked every 30 minutes for 2 hours
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
July 21, 2011
First Submitted That Met QC Criteria
July 22, 2011
First Posted (Estimate)
July 25, 2011
Study Record Updates
Last Update Posted (Estimate)
July 25, 2011
Last Update Submitted That Met QC Criteria
July 22, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS-10-00223
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperglycemia
-
Mayo ClinicCompletedHospital Hyperglycemia | Post-transplant HyperglycemiaUnited States
-
Zealand University HospitalNot yet recruitingStress Hyperglycemia | Postoperative Hyperglycemia
-
University of CopenhagenUnknownSurgery--Complications | Hyperglycemia Stress | Hyperglycemia Steroid-inducedDenmark
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
University Hospital, Gentofte, CopenhagenCompletedPancreatectomy; HyperglycemiaDenmark
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
-
National University, SingaporeNational University Health System, SingaporeCompletedPostprandial HyperglycemiaSingapore
-
Coordinación de Investigación en Salud, MexicoUnknownStress HyperglycemiaMexico
-
University of Eastern FinlandCompletedPostprandial HyperglycemiaFinland
-
University of LeedsCompletedHyperglycemia, PostprandialUnited Kingdom
Clinical Trials on Intravenous normal saline
-
MemorialCare Health SystemCompletedLength of Labor | Second Stage of Labor | Intravenous Hydration of LaborUnited States
-
MemorialCare Health SystemCompletedLabor; Forced or Induced, Affecting Fetus or NewbornUnited States
-
Direct Biologics, LLCCompletedCOVID-19 | ARDSUnited States
-
Direct Biologics, LLCRecruitingAcute Respiratory Distress Syndrome | ARDSUnited States
-
University of Alabama at BirminghamRecruitingPediatric Lumbar PunctureUnited States
-
Christiana Care Health ServicesCompleted
-
Ottawa Hospital Research InstituteWithdrawn
-
Seoul National University HospitalRecruitingRetinoblastomaKorea, Republic of
-
Hamilton Health Sciences CorporationCompletedEdema | HypoproteinemiaCanada
-
The First Affiliated Hospital with Nanjing Medical...Completed